SIGNAL GRIDv0.1

Discontinuation and reinitiation of dual-labeled GLP-1 receptor agonists

1 sources1 storiesFirst seen 3/20/2026Score28Mixed Progress
Single Source
CoverageRecencyEngagementVelocityBignessConfidenceClipability
Bigness
28
Coverage
13
Recency
67
Engagement
24
Velocity
0
Confidence
49
Clipability
60
Polarization
0
Claims
2
Contradictions
0
Breakthrough
50

Sentiment Mix

Positive0%
Neutral100%
Negative0%

Expert Signals

siquick

author1 mention

Hacker News

source1 mention

AI-Generated Claims

Generated from linked receipts; click sources for full context.

Discontinuation and reinitiation of dual-labeled GLP-1 receptor agonists.

Supported by 1 story

Study: https://pubmed.ncbi.nlm.nih.gov/39888616/

Supported by 1 story

Related Events

Timeline (1 stories)

Receipts (1)

Bias Snapshot

Center
Left 0%Center 100%Right 0%
Aggnautil.us3/20/2026